Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation

Clinical and Experimental Immunology

Volumn 179, Issue 2, 2015, Pages 300-308

  Scrivo, R ^a   Conigliaro, P ^b   Riccieri, V ^a   Di Franco, M ^a   Alessandri, C ^a   Spadaro, A ^a   Perricone, R ^b   Valesini, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

IL 10 family cytokine; Inflammatory arthritis; Serum; Synovial fluid

Indexed keywords

IL19 PROTEIN, HUMAN; INTERLEUKIN 20; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24;

ADULT; AGED; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOLOGY; INFLAMMATION; JOINT; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INFLAMMATION; INTERLEUKINS; JOINTS; MALE; MIDDLE AGED; SYNOVIAL FLUID;

EID: 84920283134     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12449     Document Type: Article

References (31)

1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365:2205-2219.
2. Leech MT, Morand EF. Fibroblasts and synovial immunity. Curr Opin Pharmacol 2013; 13:565-569.
3. Feldmann M, Brennan FM, Williams RO etal. Evaluation of the role of cytokines in autoimmune disease: the importance of TNFα in rheumatoid arthritis. Prog Growth Factor Res 1992; 4:247-255.
4. Hsu YH, Li HH, Hsieh MY etal. Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. Arthritis Rheum 2006; 54:2722-2733.
5. Brennan F, Beech J. Update on cytokines in rheumatoid arthritis. Curr Opin Rheumatol 2007; 19:296-301.
6. Furst DE, Keystone EC, So AK etal. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012. Ann Rheum Dis 2013; 72 (Suppl. 2):ii2-34.
7. Hsu YH, Chang MS. Interleukin-20 antibody is a potential therapeutic agent for experimental arthritis. Arthritis Rheum 2010; 62:3311-3321.
8. Leng RX, Pan HF, Tao JH, Ye DQ. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases. Expert Opin Ther Targets 2011; 15:119-126.
9. Commins S, Steinke JW, Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 2008; 121:1108-1111.
10. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 2001; 167:3545-3549.
11. Romer J, Hasselager E, Nørby PL, Steiniche T, Thorn Clausen J, Kragballe K. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine A or calcipotriol. J Invest Dermatol 2003; 121:1306-1311.
12. Kõks S, Kingo K, Rätsep R, Karelson M, Silm H, Vasar E. Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis. Genes Immun 2004; 5:662-667.
13. Kõks S, Kingo K, Vabrit K etal. Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes Immun 2005; 6:407-415.
14. Kingo K, Mossner R, Rätsep R etal. Association analysis of IL20RA and IL20RB genes in psoriasis. Genes Immun 2008; 9:445-451.
15. Kragstrup TW, Otkjaer K, Holm C etal. The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine 2008; 41:16-23.
16. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54:2665-2673.
17. Arnett FC, Edworthy SM, Bloch DA etal. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-324.
18. Zhang W, Doherty M, Peat G etal. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis 2010; 69:483-489.
19. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:44-48.
20. Todd DJ, Knowlton N, Amato M etal. Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor. Arthritis Rheum 2011; 63:894-903.
21. Weinberger A, Simkin PA. Plasma proteins in synovial fluids of normal human joints. Semin Arthritis Rheum 1989; 19:66-76.
22. Killingsworth LM. Clinical applications of protein determinations in biological fluids other than blood. Clin Chem 1982; 28:1093-1102.
23. Lebre MC, Lonckheere CL, Kraan MC etal. Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment. Arthritis Res Ther 2012; 14:R200.
24. Wang M, Liang P. Interleukin-24 and its receptors. Immunology 2005; 114:166-170.
25. Kohem CL, Brezinschek RI, Wisbey H, Tortorella C, Lipsky PE, Oppenheimer-Marks N. Enrichment of differentiated CD45RBdim, CD27- memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:844-854.
26. Gallagher G, Dickensheets H, Eskdale J etal. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 2000; 1:442-450.
27. Liao YC, Liang WG, Chen FW etal. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol 2002; 169:4288-4297.
28. Sakurai N, Kuroiwa T, Ikeuchi H etal. Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology 2008; 47:815-820.
29. Alanara T, Karstila K, Moilanen T, Silvennoinen O, Isomaki P. Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints. Scand J Rheumatol 2010; 39:118-126.
30. Li HH, Lin YC, Chen PJ etal. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br J Dermatol 2005; 153:591-595.
31. Hsu YH, Hsieh PP, Chang MS. Interleukin-19 blockade attenuates collagen-induced arthritis in rats. Rheumatology (Oxf) 2012; 51:434-442.